Trial
NCT00932152
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
—
Condition
Non-small Cell Lung Cancer
Intervention
fulvestrant (Faslodex)
Why stopped
Poor enrollment/suspended to accrual; will close per AstraZeneca request
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-19